XML 18 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Income Statement [Abstract]      
Revenues $ 349,435 $ 371,112 $ 361,772
Cost of revenues 246,487 286,670 249,543
Gross profit 102,948 84,442 112,229
Operating expenses:      
Research and development, net 22,930 35,004 42,962
Selling and marketing 40,816 56,059 67,743
General and administrative 21,235 23,657 26,757
Restructuring costs $ 1,225 6,816 $ 9,345
Goodwill impairment 14,765 [1]
Other income $ (4,849) (19,827) $ (7,657)
Total operating expenses 81,357 116,474 139,150
Operating income (loss) 21,591 (32,032) (26,921)
Financial expenses, net 14,738 37,946 14,018
Income (loss) before taxes on income 6,853 (69,978) (40,939)
Taxes on income 5,842 6,501 6,539
Net income (loss) $ 1,011 $ (76,479) $ (47,478)
Net Income (loss) per share:      
Basic net income (loss) per share $ 0.01 $ (1.22) $ (1.23)
Diluted net income (loss) per share $ 0.01 $ (1.22) $ (1.23)
Weighted average number of ordinary shares used in computing basic net income (loss) per share 77,239,409 62,518,602 38,519,606
Weighted average number of ordinary shares used in computing diluted net income (loss) per share 77,296,681 62,518,602 38,519,606
[1] During the fourth quarter of 2014, the Company determined that sufficient indicators of potential impairment existed to require additional goodwill impairment analysis. These indicators included the trading value of the Company's stock at the time of the impairment test, coupled with existing market conditions and business trends. Based on the step one and step two analyses (see also note 2l), the Company recorded complete goodwill impairment charge in 2014, in the amount of $ 14,765.